Navigation Links
Go Healthy Initiates Additional Clinical Tests on Cholesterade
Date:5/8/2008

HOUSTON, May 8 /PRNewswire-FirstCall/ -- Go Healthy (Pink Sheets: GOHE) announces the initiation of further clinical trials with Cholesterade (R) in three medical settings with an expected patient clinical group of 200 patients in 6 centers around the country. Dr. William Bryan of the Sports Medicine Institute at The Methodist Hospital in the Texas Medical Center will coordinate one clinical trial. Dr. Bryan was formerly the Team Physician for the Houston Astros and the former Medical Director of Major League Baseball.

Dr. David Braunreiter of Memorial Hermann Hospital, the Team Physician for the Houston Dynamo and the NFL's Houston Texans will coordinate a center in Southwest Houston. Dr. Jason Pirozzolo of the Sports Medicine Institute at the Florida Hospital in Orlando will coordinate a third center, pending IRB approval. Pirozzolo recently completed Sports Medicine fellowships at the Ohio State University and Duke University.

Future centers will be coordinated by CO-PIs, Dr. Hal Goforth, widely acclaimed researcher on muscle glycogen metabolism from Point Loma Nazarene University and the Naval Research Center, and Dr. Fran Pirozzolo, Chairman of the Medical and Scientific Advisory Board of Go Healthy. Dr. Fran Pirozzolo was formerly the Chief of the Neuropsychology Service in the Department of Neurology at the Baylor College of Medicine. He was a Member of the National Academy of Sciences Committee on Techniques to Enhance Human Performance and has served on a number of NIH and NIMH advisory committees.

The study will be a double-blind crossover study of the efficacy of Cholesterade(R) in lowering cholesterol (total cholesterol and LDL) and triglycerides while increasing HDL and HDLC/LDLC ratio. The study will also employ a modified Experience Sampling Technique to measure the vitality of subjects throughout the day.

Charlie Caudle, CEO of Go Healthy, states that "We are very excited to be moving forward on studies that will expand on Dr. Cade's work and which we believe will conclusively demonstrate that Cholesterade(R) will bring a dramatic, meaningful contribution to the improvement of health in the cholesterol and other areas, including obesity and diabetes. This delicious drink will now allow the medical community to provide a compliance vehicle to meet NIH guidelines for 10-25 grams of dietary soluble fiber during a 12 week period of Therapeutic Lifestyle Changes prior to consideration of statin intervention. Subsequent studies we are planning will delve into those other areas and demonstrate the vital importance of dietary soluble fiber in general wellness."

Forward-Looking Statements Disclosure

This press release may contain "forward-looking statements" within the meaning of the federal securities laws. In this context, forward-looking statements may address the Company's expected future business and financial performance, and often contain words such as "anticipates," "believes," "estimates," "expects," "intends," "plans," "seeks," "will," and other terms with similar meaning. These forward-looking statements by their nature address matters that are, to different degrees, uncertain. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can provide no assurances that these assumptions will prove to be correct. All forward-looking statements in this press release are expressly qualified by such cautionary statements, risks, and uncertainties, and by reference to the underlying assumptions.

Contact:

Charlie Caudle

CEO - Go Healthy, Inc.

(888) 282-7256

Brokers and Analysts call

Aero Financial, Inc

972-265-7590


'/>"/>
SOURCE Go Healthy, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
2. New Study Shows Concord Grape Juice has a Heart-Healthy Effect not yet Reported With Red Wine
3. Concentra Medical Centers Gears Up for Flu Season to Keep Area Workforce Healthy
4. Folate in Strawberries May Contribute to Healthy Pregnancy
5. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
6. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
9. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
10. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
11. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... MENLO PARK, Calif. , Oct. 11, 2017 /PRNewswire/ ... a national scientific team that developed an innovative way ... and quantity of the delivery of new drugs. ... the 2017 Fall Clinical Dermatology Conference will show how ... Massachusetts General Hospital, Harvard Medical School used a suite ...
(Date:10/10/2017)...  NDS received FDA 510(k) clearance in May 2017 for its ... specifically designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... to support the improvement of patient outcomes, procedural efficiency, and the ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
Breaking Medicine Technology:
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
Breaking Medicine News(10 mins):